While we all want to lower drug costs, we do not believe that expanding the PDAB’s Upper Payment Limit (UPL) authority will actually save patients money. Instead, we have significant concerns that SB 357 could unintentionally restrict access to critical medications, discourage investment in new treatments, and reduce funding to safety net programs that already help patients afford life-saving drugs.
Support for ND HB 1216 to Ban Copay Accumulators
When patients are forced to forego their medications due to high costs, the consequences are severe—not just for individual health outcomes, but also for public health and healthcare system costs. Policies that limit access to copay assistance exacerbate these challenges, disproportionately affecting those who are already vulnerable. House Bill 1216 represents an essential safeguard against harmful insurer practices, ensuring equitable access to life-saving treatments for North Dakota residents.
Support for NJ A-5217 to Ban Copay Accumulators
The HIV+Hepatitis Policy Institute, a leading organization advocating for equitable and affordable healthcare for individuals living with or at risk of HIV, hepatitis, and other chronic health conditions, strongly supports Assembly Bill 5217. This vital legislation ensures that health insurers accept and count payments made on behalf of patients toward their deductibles and out-of-pocket maximums.
Support for Missouri Senate bill 45 to ensure all copays count for patients
The HIV+Hepatitis Policy Institute, a leading organization advocating for equitable and affordable healthcare for individuals living with or at risk of HIV, hepatitis, and other chronic health conditions, strongly supports Senate Bill 45. This vital legislation ensures that health insurers accept and count payments made on behalf of patients toward their deductibles and out-of-pocket maximums.
Testimony Supporting NH’s SB 17 to Ensure Copay Assistance Counts toward Patient Costs
By passing Senate Bill 17, New Hampshire will join 21 other states, the District of Columbia, and Puerto Rico in protecting consumers purchasing insurance on the private market. This legislation ensures that copay assistance counts toward cost-sharing obligations, preventing patients from facing insurmountable financial barriers to their medications.